167.60
price down icon1.19%   -2.01
 
loading
Precedente Chiudi:
$169.61
Aprire:
$167.26
Volume 24 ore:
806.06K
Relative Volume:
0.71
Capitalizzazione di mercato:
$9.46B
Reddito:
$763.34M
Utile/perdita netta:
$51.40M
Rapporto P/E:
184.50
EPS:
0.9084
Flusso di cassa netto:
$104.46M
1 W Prestazione:
-4.92%
1M Prestazione:
+11.90%
6M Prestazione:
+33.18%
1 anno Prestazione:
+38.99%
Intervallo 1D:
Value
$165.00
$169.51
Intervallo di 1 settimana:
Value
$165.00
$182.57
Portata 52W:
Value
$100.99
$188.73

Repligen Corp Stock (RGEN) Company Profile

Name
Nome
Repligen Corp
Name
Telefono
(781) 449-9560
Name
Indirizzo
41 SEYON STREET, WALTHAM, MA
Name
Dipendente
2,000
Name
Cinguettio
@repligen
Name
Prossima data di guadagno
2026-07-28
Name
Ultimi documenti SEC
Name
RGEN's Discussions on Twitter

Compare RGEN vs ISRG, BDX, ALC, RMD, MDLN

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
RGEN icon
RGEN
Repligen Corp
167.60 10.17B 763.34M 51.40M 104.46M 0.9084
ISRG icon
ISRG
Intuitive Surgical Inc
366.70 132.30B 11.03B 3.16B 3.22B 8.7251
BDX icon
BDX
Becton Dickinson Co
184.74 51.11B 21.37B 1.41B 3.07B 3.9437
ALC icon
ALC
Alcon Inc
70.50 35.25B 10.63B 819.00M 1.59B 1.6577
RMD icon
RMD
Resmed Inc
228.35 32.95B 5.54B 1.52B 1.74B 10.37
MDLN icon
MDLN
Medline Inc
36.59 28.58B 29.14B 1.07B 1.05B 1.1956

Repligen Corp Stock (RGEN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2026-04-17 Iniziato Rothschild & Co Redburn Buy
2025-10-01 Iniziato HSBC Securities Buy
2025-09-22 Aggiornamento Evercore ISI In-line → Outperform
2025-07-22 Ripresa Stephens Overweight
2025-06-24 Iniziato Barclays Overweight
2025-04-29 Aggiornamento Wolfe Research Peer Perform → Outperform
2025-03-18 Iniziato Evercore ISI In-line
2025-02-10 Iniziato TD Cowen Buy
2024-12-17 Iniziato Canaccord Genuity Hold
2024-11-14 Iniziato Wolfe Research Peer Perform
2024-08-28 Iniziato Wells Fargo Overweight
2024-06-26 Aggiornamento Deutsche Bank Hold → Buy
2024-06-18 Iniziato Guggenheim Neutral
2023-12-04 Downgrade The Benchmark Company Buy → Hold
2023-07-20 Iniziato Wells Fargo Overweight
2023-07-05 Ripresa JP Morgan Overweight
2023-03-28 Iniziato The Benchmark Company Buy
2022-12-14 Iniziato Deutsche Bank Hold
2022-12-07 Iniziato RBC Capital Mkts Sector Perform
2022-07-20 Iniziato UBS Buy
2021-10-14 Iniziato Exane BNP Paribas Outperform
2020-11-10 Iniziato KeyBanc Capital Markets Overweight
2020-08-24 Reiterato H.C. Wainwright Buy
2020-06-30 Reiterato H.C. Wainwright Buy
2020-05-07 Reiterato H.C. Wainwright Buy
2020-03-23 Reiterato H.C. Wainwright Buy
2019-11-15 Iniziato Stifel Buy
2019-11-01 Aggiornamento First Analysis Sec Outperform → Strong Buy
2019-10-15 Iniziato SVB Leerink Outperform
2019-08-28 Reiterato First Analysis Sec Outperform
2019-08-23 Ripresa Stephens Overweight
2019-07-22 Aggiornamento H.C. Wainwright Neutral → Buy
2018-12-17 Aggiornamento CL King Neutral → Buy
2018-11-12 Downgrade CL King Buy → Neutral
2018-09-26 Iniziato H.C. Wainwright Neutral
2017-12-08 Iniziato Citigroup Buy
2017-12-05 Iniziato JP Morgan Overweight
2017-11-13 Iniziato CL King Buy
2017-10-02 Aggiornamento First Analysis Sec Equal-Weight → Overweight
2017-07-21 Iniziato William Blair Outperform
2017-02-13 Aggiornamento Piper Jaffray Neutral → Overweight
Mostra tutto

Repligen Corp Borsa (RGEN) Ultime notizie

pulisher
Aug 21, 2026

Repligen Corp (RGEN) CEO Olivier Loeillot Sells 5,426 Shares - GuruFocus

Aug 21, 2026
pulisher
Aug 21, 2026

Repligen (NASDAQ: RGEN) CEO trades shares at $180 under 10b5-1 plan - Stock Titan

Aug 21, 2026
pulisher
Aug 20, 2026

LVIP Baron Growth Opportunities Fund's Repligen Corp(RGEN) Holding History - GuruFocus

Aug 20, 2026
pulisher
Aug 20, 2026

Repligen rises as investors continue to digest raised 2026 guidance and the BioLife deal - Quiver Quantitative

Aug 20, 2026
pulisher
Aug 20, 2026

Repligen (NASDAQ: RGEN) plan covers 5,426-share sale after option exercise - Stock Titan

Aug 20, 2026
pulisher
Aug 19, 2026

Repligen Corporation stock hits 52-week high at 176.52 USD By Investing.com - Investing.com South Africa

Aug 19, 2026
pulisher
Aug 19, 2026

Repligen Corporation stock hits 52-week high at 176.52 USD - Investing.com

Aug 19, 2026
pulisher
Aug 16, 2026

Oppenheimer Asset Management Inc. Purchases New Position in Repligen Corporation $RGEN - MarketBeat

Aug 16, 2026
pulisher
Aug 14, 2026

Repligen Corp (RGEN) stake at 3.1% in new T. Rowe Price 13G/A - Stock Titan

Aug 14, 2026
pulisher
Aug 13, 2026

Repligen Corporation (RGEN) Stock Forecasts - Yahoo! Finance Canada

Aug 13, 2026
pulisher
Aug 12, 2026

Wasatch Advisors LP Buys 346,720 Shares of Repligen Corporation $RGEN - MarketBeat

Aug 12, 2026
pulisher
Aug 12, 2026

Assenagon Asset Management S.A. Buys New Shares in Repligen Corporation $RGEN - MarketBeat

Aug 12, 2026
pulisher
Aug 10, 2026

Repligen Corporation (RGEN) stock price, news, quote and history - Yahoo Finance UK

Aug 10, 2026
pulisher
Aug 10, 2026

Repligen Corporation (NASDAQ:RGEN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Aug 10, 2026
pulisher
Aug 09, 2026

Repligen (RGEN) Is Up 16.2% After Revenue Rises But Profitability Compresses In Q2 2026 - Yahoo Finance

Aug 09, 2026
pulisher
Aug 07, 2026

Repligen Corp (RGEN) Stock News Today - TradingKey

Aug 07, 2026
pulisher
Aug 07, 2026

Repligen Corp (RGEN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 07, 2026
pulisher
Aug 06, 2026

The Manufacturers Life Insurance Company Decreases Holdings in Repligen Corporation $RGEN - MarketBeat

Aug 06, 2026
pulisher
Aug 05, 2026

Is It Too Late to Buy Repligen Corp (RGEN) After 5.8% Rally? GF Value Says Undervalued - GuruFocus

Aug 05, 2026
pulisher
Aug 05, 2026

Moody National Bank Trust Division Makes New Investment in Repligen Corporation $RGEN - MarketBeat

Aug 05, 2026
pulisher
Aug 05, 2026

California State Teachers Retirement System Raises Holdings in Repligen Corporation $RGEN - MarketBeat

Aug 05, 2026
pulisher
Aug 04, 2026

Repligen Submits Form 425 Detailing Proposed Acquisition of BioLife Solutions - Kalkine Media

Aug 04, 2026
pulisher
Aug 03, 2026

Repligen Corp (RGEN) Stock Up 4.3% and Still Undervalued -- GF S - GuruFocus

Aug 03, 2026
pulisher
Aug 01, 2026

Repligen Earnings: Excellent Profit Margins, China Recovery Underway - Morningstar

Aug 01, 2026
pulisher
Aug 01, 2026

Repligen Corporation $RGEN Shares Acquired by Avidity Partners Management LP - MarketBeat

Aug 01, 2026
pulisher
Jul 31, 2026

Vanguard Capital Management reports 5% Repligen (RGEN) stake in Schedule 13G - Stock Titan

Jul 31, 2026
pulisher
Jul 30, 2026

Repligen Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs

Jul 30, 2026
pulisher
Jul 30, 2026

Wall Street Analysts Believe Repligen (RGEN) Could Rally 25.72%: Here's is How to Trade - Yahoo Finance

Jul 30, 2026
pulisher
Jul 29, 2026

Repligen Beats Q2 Earnings Estimates, Raises 2026 View, Stock Up - Barchart.com

Jul 29, 2026
pulisher
Jul 29, 2026

Canaccord reiterates Hold on Repligen stock, keeps $145 target By Investing.com - Investing.com Nigeria

Jul 29, 2026
pulisher
Jul 29, 2026

Repligen Offers Differentiated Solutions as a Leading Bioprocessing Supplier - Morningstar

Jul 29, 2026
pulisher
Jul 28, 2026

Repligen Corp (RGEN) Shares Surge 11.0% -- What GF Score of 87 T - GuruFocus

Jul 28, 2026
pulisher
Jul 28, 2026

Repligen Corp reports results for the quarter ended June 30Earnings Summary - TradingView

Jul 28, 2026
pulisher
Jul 28, 2026

Repligen Corp (RGEN) Q2 2026 Earnings Call Transcript - AlphaStreet

Jul 28, 2026
pulisher
Jul 28, 2026

Is Repligen Corp (RGEN) Undervalued After Q2 Earnings Beat? EPS - GuruFocus

Jul 28, 2026
pulisher
Jul 28, 2026

Repligen raises FY2026 adj EPS guidance to $2.03-$2.09 - scanx.trade

Jul 28, 2026
pulisher
Jul 28, 2026

Repligen Reports Q2 2026: Revenue $204M, Adjusted EPS $0.54; Raises FY26 Guidance - TradingView

Jul 28, 2026
pulisher
Jul 28, 2026

Repligen Q2 2026 revenue rises 12% to $204 million - Quiver Quantitative

Jul 28, 2026
pulisher
Jul 28, 2026

Repligen Reports Q2 2026 Revenue Growth, Raises Full-Year Organic Revenue and EPS Guidance - Quiver Quantitative

Jul 28, 2026
pulisher
Jul 28, 2026

Repligen: Q2 Earnings Snapshot - Yahoo Finance

Jul 28, 2026
pulisher
Jul 28, 2026

Repligen Reports Second Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance - Yahoo Finance

Jul 28, 2026
pulisher
Jul 27, 2026

Repligen Corp (RGEN) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Repligen Corp (RGEN) Balance Sheet - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Repligen Corp (RGEN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Repligen earnings in focus after $1.5B BioLife acquisition By Investing.com - Investing.com South Africa

Jul 27, 2026
pulisher
Jul 27, 2026

Repligen Corp (RGEN) Institutional Confidence - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

RGEN|Repligen Corp|Price:131.960|Chg%:-5.640 - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Repligen Corp (RGEN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Repligen (RGEN) Q2 Earnings: What To Expect - Yahoo! Finance Canada

Jul 27, 2026
pulisher
Jul 27, 2026

Repligen Corp (RGEN) Cash Flow - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

ETFs Investing in Repligen Corporation Stocks - TradingView

Jul 27, 2026

Repligen Corp Azioni (RGEN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Repligen Corp Azioni (RGEN) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Loeillot Olivier
Chief Executive Officer
Aug 20 '26
Option Exercise
141.79
5,426
769,353
59,672
Loeillot Olivier
Chief Executive Officer
Aug 20 '26
Sale
180.00
5,426
976,680
54,246
$158.63
price down icon 0.76%
BAX BAX
$25.83
price up icon 1.02%
COO COO
$69.59
price down icon 1.49%
$91.69
price down icon 0.81%
WST WST
$339.97
price down icon 0.81%
$36.59
price up icon 0.00%
Capitalizzazione:     |  Volume (24 ore):